Koné-Paut, Isabelle
Georgin-Lavialle, Sophie
Belot, Alexandre
Jover, Magali
Pouriel, Mathilde
Lacoin, Laure
Pillet, Pascal
Hentgen, Véronique
Article History
Received: 11 September 2023
Accepted: 27 March 2024
First Online: 8 April 2024
Declarations
:
: IKP has received consulting fees, speaking fees and/or honoraria Novartis, SOBI, LFB, Abbvie, Pfizer, Chugai, Amgen, Zydus. SG has received consulting fees, speaking fees and/or honoraria from Novartis and SOBI. AB has received research grant from Boehringer Ingelheim and Merck Serono and consulting fees from Novartis, Abbvie, GSK, Roche Chugai. MJ is an employee of Novartis. MP is an employee of I&M STAT working for Novartis. LL has received consulting fees from Novartis. PP has received consulting fees, speaking fees and/or honoraria from Novartis and SOBI. VH has received consulting fees, speaking fees and/or honoraria from Novartis, SOBI and MSD vaccin.
: Patients were enrolled after confirmation that they (or their legal guardian) were not opposed to the study and the storage of their personal data. The JIR cohort protocol was approved by the French Ethics Committee (CCTIRS) and by the National Commission of data processing and liberties (CNIL).
: Not applicable.